| 1 |
Nanopolymersomes as potential carriers for rifampicin pulmonary delivery |
|
|
| Marcela A. Moretton,Maximiliano Cagel,Ezequiel Bernabeu,Lorena Gonzalez,Diego A. Chiappetta |
|
| Colloids and Surfaces B: Biointerfaces. 2015; 136: 1017 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis |
|
|
| Eleonora Maretti,Tiziana Rossi,Moreno Bondi,Maria Antonietta Croce,Miriam Hanuskova,Eliana Leo,Francesca Sacchetti,Valentina Iannuccelli |
|
| International Journal of Pharmaceutics. 2014; 462(1-2): 74 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
The Influence of Feedstock and Process Variables on the Encapsulation of Drug Suspensions by Spray-Drying in Fast Drying Regime: The Case of Novel Antitubercular Drug-Palladium Complex Containing Polymeric Microparticles |
|
|
| Stefano Giovagnoli,Francesco Palazzo,Alessandro Di Michele,Aurelie Schoubben,Paolo Blasi,Maurizio Ricci |
|
| Journal of Pharmaceutical Sciences. 2014; 103(4): 1255 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
In Silico children and the glass mouse model: Clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis |
|
|
| Jeena, P.M., Bishai, W.R., Pasipanodya, J.G., Gumbo, T. |
|
| Antimicrobial Agents and Chemotherapy. 2011; 55(2): 539-545 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
An oracle: Antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future |
|
|
| Pasipanodya, J., Gumbo, T. |
|
| Antimicrobial Agents and Chemotherapy. 2011; 55(1): 24-34 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Penetration of Anti-Infective Agents into PulmonaryEpithelial Lining Fluid : Focus on Antifungal, Antitubercular and Miscellaneous Anti-Infective Agents |
|
|
| Keith A. Rodvold, Liz Yoo, Jomy M. George |
|
| Clinical Pharmacokinetics. 2011; 50(11): 689 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 7 |
New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability |
|
|
| Gumbo, T. |
|
| Antimicrobial Agents and Chemotherapy. 2010; 54(4): 1484-1491 |
|
| [Pubmed] [Google Scholar] |
|
